RecruitingNCT05739591
Long-term Safety and Efficacy of GBG Study Participants
Registry for Long-term Follow-up of Safety and Efficacy Parameters of GBG Study Participants
Sponsor
GBG Forschungs GmbH
Enrollment
400 participants
Start Date
Oct 12, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Participation and treatment in a GBG clinical trial for early breast cancer.
- Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.
Exclusion Criteria2
- Participation and treatment in a non-GBG clinical trial for early breast cancer.
- Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05739591
Related Trials
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
NCT069260753 locations
Cardiac Outcomes With Near-Complete Estrogen Deprivation
NCT053096553 locations
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT041190243 locations
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
NCT074780161 location